Your Catalyst to a Lucrative Business
Medical Morphine Market Share, Size,Growth, Segmenatation,
Outlook and Forecasts to 2024 | Hexa Research
“ The global medical morphine market is expected to reach USD 13.32 billion
by 2024.”
28 November 2018
The global medical morphine market is expected to reach USD 13.32 billion by 2024, driven by increasing morphine
consumption in the U.S. The increasing prevalence of arthritis and cancer in geriatric patients is projected to impact the
morphine market globally positively.
North America dominated the market by contributing more than 75.0% of the share in 2016 and continue to dominate
owing to the increasing number of prescriptions for morphine in the U.S. North American market for the same is
expected to grow at a CAGR of 2.9% over the forecast period. However, lack of availability of medical morphine in
countries such as India is expected to hamper the growth of the market.
In terms of route of administration, the oral segment is expected to grow at the fastest CAGR over the projected period
owing to its dose accuracy, high accessibility, and ease of carrying compared to injectables and other counterparts.
On the basis of indication, others segment is expected to grow at the fastest CAGR of 3.1% over the forecast period
owing to increasing number of prescriptions of morphine in U.S. for nominal conditions. The cancer segment is expected
to exhibit lucrative growth due to increasing prevalence of bone cancer globally.
Browse Details of Report @ https://www.hexaresearch.com/research-report/medical-morphine-market
Morphine with its use in therapeutics is also one of the most abused drug globally. Respective
governments are introducing initiatives to prevent substance abuse and decrease death rates caused
by morphine. Furthermore, researchers are concentrating on drug abuse treatment for opioid addicts
which is expected to reduce the illicit use of morphine. For instance, in August 2017, researchers at
Follow Us: